The incidence of hypoglycaemia in children with type 1 diabetes and treated asthma

Archives of Disease in Childhood

Volumn 88, Issue 2, 2003, Pages 155-156

  Wright, N P ^a   Wales, J K H ^a  

^a SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; HEMOGLOBIN A1C; INSULIN; SALBUTAMOL; STEROID; TERBUTALINE;

ARTICLE; ASTHMA; CHILD; COMORBIDITY; DIABETES CONTROL; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENERGIC BETA-AGONISTS; ASTHMA; CHILD; DIABETES COMPLICATIONS; DIABETES MELLITUS; DRUG THERAPY, COMBINATION; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; STEROIDS;

EID: 0037311752     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.88.2.155     Document Type: Article

References (7)

1. Smith AP, Banks J, Buchanan K, et al. Mechanisms of abnormal glucose metabolism during the treatment of acute severe asthma. QJM 1992;82:71-80.
2. Wiethop BY, Cryer PE. Glycemic actions of alanine and terbutaline in IDDM. Diabetes Care 1993;16:1124-30.
3. Dawson KP, Penna AC, Manglick P. Acute asthma, salbutamol and hyperglycaemia. Acta Paediatr 1995;84:305-7.
4. Wiethop BV, Cryer PE. Alanine and terbutaline in treatment of hypoglycemia in IDDM. Diabetes Care 1993;16:1131-6.
5. Saleh TY, Cryer PE. Alanine and terbutaline in the prevention of nocturnal hypoglycaemia in IDDM. Diabetes Care 1997;20:1231-6.
6. Strachan DP, Anderson HR, Limb ES, et al. A national survey of asthma prevalence, severity, and treatment in Great Britain. Arch Dis Child 1994;70:174-8.
7. Fanelli CG, Epifano L, Rambotti AM, et al. Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 1993;42:1683-9.